TCIM
PFE icon

TIAA CREF Investment Management’s Pfizer PFE Stock Holding History

TIAA CREF Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$885M Sell
21,965,527
-1,342,125
-6% -$53.7M 0.63% 32
2018
Q4 		$965M Sell
23,307,652
-552,383
-2% -$22.9M 0.76% 21
2018
Q3 		$998M Sell
23,860,035
-801,923
-3% -$30.9M 0.65% 22
2018
Q2 		$849M Sell
24,661,958
-229,971
-0.9% -$7.86M 0.57% 30
2018
Q1 		$838M Sell
24,891,929
-4,594,818
-16% -$158M 0.57% 31
2017
Q4 		$1.01B Buy
29,486,747
+1,120,478
+4% +$38.2M 0.67% 21
2017
Q3 		$961M Buy
28,366,269
+3,020,944
+12% +$97.1M 0.66% 20
2017
Q2 		$808M Sell
25,345,325
-1,112,772
-4% -$35.1M 0.57% 30
2017
Q1 		$859M Sell
26,458,097
-1,573,227
-6% -$49.6M 0.62% 25
2016
Q4 		$864M Sell
28,031,324
-522,653
-2% -$16M 0.64% 24
2016
Q3 		$918K Sell
28,553,977
-1,822,165
-6% -$60.9M 0.57% 33
2016
Q2 		$1.01B Buy
30,376,142
+2,629,714
+9% +$83.9M 0.78% 17
2016
Q1 		$780M Sell
27,746,428
-7,497,349
-21% -$214M 0.6% 31
2015
Q4 		$1.08B Buy
35,243,777
+614,640
+2% +$19.3M 0.81% 18
2015
Q3 		$1.03B Buy
34,629,137
+184,701
+0.5% +$5.92M 0.81% 16
2015
Q2 		$1.1B Sell
34,444,436
-1,672,661
-5% -$54.5M 0.78% 17
2015
Q1 		$1.19B Buy
36,117,097
+5,555,691
+18% +$177M 0.83% 14
2014
Q4 		$903M Sell
30,561,406
-3,118,893
-9% -$89.4M 0.63% 25
2014
Q3 		$945M Sell
33,680,299
-2,174,918
-6% -$61M 0.67% 24
2014
Q2 		$1.01B Sell
35,855,217
-1,879,765
-5% -$53.6M 0.7% 19
2014
Q1 		$1.15B Sell
37,734,982
-912,652
-2% -$27.2M 0.83% 14
2013
Q4 		$1.12B Buy
38,647,634
+890,284
+2% +$25.9M 0.81% 14
2013
Q3 		$1.03B Sell
37,757,350
-5,486,402
-13% -$149M 0.8% 14
2013
Q2 		$1.15B Buy
+43,243,752
New +$1.19B 0.94% 10

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIAA CREF Investment Management's PFE Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Pfizer (PFE) stake by 5.8% in Q1 2019, selling an estimated $53.7M and leaving 21,965,527 shares worth $885M. The position accounts for 0.63% of the portfolio, ranked #32.

TIAA CREF Investment Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.19B in Q1 2015. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • TIAA CREF Investment Management held 21,965,527 shares of Pfizer worth $885M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,342,125 Pfizer shares in Q1 2019, an estimated $53.7M.
  • Pfizer made up 0.63% of TIAA CREF Investment Management's portfolio in Q1 2019, its #32 holding.
  • TIAA CREF Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Pfizer position peaked at $1.19B in Q1 2015.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.